Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Comparison Of The Analgesia Obtained By Infiltration For The Joinings Of Episiotomies (Liropep) (LiRoPep)

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Angers
ClinicalTrials.gov Identifier:
NCT00727935
First received: July 30, 2008
Last updated: August 4, 2008
Last verified: August 2008
  Purpose

Lateral episiotomy is a current care practiced with childbirth room. One of the problems encountered with this surgical act is the residual pain on perineal scar level. Maximal during the first 24 hours, this pain can persist several days or several weeks hampering to variable degrees a normal recovery of autonomy and comfort of life. Some studies have shown the interest of ropivacaine, local anaesthetic with a long action's duration for proctologic surgeries and for the cure of inguinal hernia. A recent study shown the ropivacaine perineal infiltration used prior perineorrhaphy allows an absence of post-partum pain for 24 to 27% of cases and a first analgesics request delayed to ten hours.

Methodology: 165 parturients having an epidural analgesia and an episiotomy were enrolled. The perineal infiltration was randomized according to 3 equal groups (placebo, ropivacaine 0,75%, lidocaine 1%) and realised prior perineorrhaphy. then The parturient were followed during the 24 first hours. This study was designed as double blind and the study conduct was standardized in order to get only variable such as the episiotomy infiltration.


Condition Intervention Phase
Parturients
Childbirth
Drug: Lidocaïne
Drug: Ropivacaïne
Drug: Placebo
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Prevention
Official Title: Comparison Of The Analgesia Obtained By Infiltration Of Lidocaïne 1% And Ropivacaïne 0,75% Versus Placebo For The Joinings Of Episiotomies Among Parturients Under Epidural Analgesia

Resource links provided by NLM:


Further study details as provided by University Hospital, Angers:

Primary Outcome Measures:
  • Time between the infiltration of the local anaesthetic and the first analgesics catch per os, which is managed when the level of pain evaluated by EVA is higher than 30 mm [ Time Frame: 1 year ]

Secondary Outcome Measures:
  • To compare between the 3 groups the mean level of the pain during the first 24 hours following the joining of the episiotomy, measured by EVA [ Time Frame: 24 hours ]
  • To compare between the 3 groups the analgesics overall consumption per os during the first 24 hours following the joining of the episiotomy [ Time Frame: 24 hours ]
  • To compare between the 3 groups the total cost of the analgesics consumption (local anaesthetic employed and analgesics per bone) during the first 24 hours following the joining of the episiotomy [ Time Frame: 24 hours ]

Enrollment: 165
Study Start Date: October 2006
Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Female
Criteria

Pre-inclusion criteria :

  • Assent of participation in the study signed
  • Major parturient (> 18 years) in the course of work in room of childbirth
  • Mono-foetal pregnancy
  • Presentation at the top

Inclusion Criteria:

  • Checking of the criteria of pre-inclusion
  • Oral confirmation of the assent of the patient
  • ASA 1 or 2
  • Childbirth by low way
  • Patient having an epidural analgesia
  • Patient having an episiotomy
  • Counter-indication with the ropivacaïne

Pre-exclusion criteria :

  • Absence of signed assent of participation in the study
  • Counter indication with the lidocaïne
  • General counter-indications suitable for the epidural anaesthesia , independently of the local anaesthetic used
  • Counter-indications with the infiltration: patient under anticoagulants, coagulopathy
  • Allergy to the lidocaine or the ropivacaine
  • Allergy to the one of analgesics per bones used in the assumption of responsibility of routine
  • Severe insufficiency hepatic and/or renal and/or ulcerates gastro-duodénal (in the case of anti-inflammatory drug regulation not steroid during the postpartum)
  • Minor
  • Major protected within the meaning of the law Huriet
  • Patient during one time of exclusion following another biomedical study

Exclusion Criteria:

  • Absence of oral confirmation of the assent of the patient
  • Infection or ignition of the point of puncture
  • Analgesia epidural not functional
  • Dural breach
  • Appearance of ascribable side effects to only the anaesthetic buildings at the time of epidural analgesia
  • Median Episiotomy (increased risk of lesions of the sphincter)
  • Need for an instrumentation at the time of expulsion
  • Haemorrhage of the delivery requiring a blood transfusion and/or general anaesthesia in urgency with surgical operation for haemostasis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00727935

Locations
France
Centre Hospitalier Universitaire
Angers, Pays-de-la-Loire, France, 49933
Sponsors and Collaborators
University Hospital, Angers
Investigators
Principal Investigator: Laurent Colbus, MD Centre Hospitalier Universitaire Angers
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00727935     History of Changes
Other Study ID Numbers: CHU P 2006-03
Study First Received: July 30, 2008
Last Updated: August 4, 2008
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Keywords provided by University Hospital, Angers:
Women
parturients
with
realization
episiotomy

Additional relevant MeSH terms:
Lidocaine
Ropivacaine
Anesthetics
Anesthetics, Local
Anti-Arrhythmia Agents
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Sodium Channel Blockers
Therapeutic Uses
Voltage-Gated Sodium Channel Blockers

ClinicalTrials.gov processed this record on November 23, 2014